61 – 70 of 297
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Point-of-care biomarkers in asthma management : Time to move forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A new role for “eat me” and “don’t eat me” markers on neutrophils in asthmatic airway inflammation
(
- Contribution to journal › Letter
- 2019
-
Mark
Osteopontin protects against pneumococcal infection in a murine model of allergic airway inflammation
(
- Contribution to journal › Article
-
Mark
Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis
(
- Contribution to journal › Article
-
Mark
EUFOREA consensus on biologics for CRSwNP with or without asthma
(
- Contribution to journal › Scientific review
-
Mark
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma
(
- Contribution to journal › Article
-
Mark
The potential role of CD16highCD62Ldim neutrophils in the allergic asthma
(
- Contribution to journal › Letter
-
Mark
The REal Life EVidence AssessmeNt Tool (RELEVANT) : Development of a novel quality assurance asset to rate observational comparative effectiveness research studies
(
- Contribution to journal › Article
-
Mark
Quality standards in respiratory real-life effectiveness research : The REal Life EVidence AssessmeNt Tool (RELEVANT): Report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force
(
- Contribution to journal › Article